Literature DB >> 27688063

Agreement between region-of-interest- and parametric map-based hepatic proton density fat fraction estimation in adults with chronic liver disease.

Paul M Manning1, Gavin Hamilton2, Kang Wang2, Chulhyun Park2, Jonathan C Hooker2, Tanya Wolfson3, Anthony Gamst3, William M Haufe2, Alex N Schlein2, Michael S Middleton2, Claude B Sirlin2.   

Abstract

PURPOSE: To compare agreement between region-of-interest (ROI)- and parametric map-based methods of hepatic proton density fat fraction (PDFF) estimation in adults with known or suspected hepatic steatosis secondary to chronic liver disease over a range of imaging and analysis conditions.
MATERIALS AND METHODS: In this IRB approved HIPAA compliant prospective single-site study, 31 adults with chronic liver disease undergoing clinical gadoxetic acid-enhanced liver magnetic resonance imaging at 3 T were recruited. Multi-echo gradient-echo imaging at flip angles of 10° and 50° was performed before and after administration of gadoxetic acid. Six echoes were acquired at successive nominally out-of-phase and in-phase echo times. PDFF was estimated with a nonlinear fitting algorithm using the first two, three, four, five, and (all) six echoes. Hence, 20 different imaging and analysis conditions were used (pre/post contrast x low/high flip angle x 2/3/4/5/6 echoes). For each condition, PDFF estimation was done in corresponding liver locations using two methods: a region-of-interest (ROI)-based method in which mean signal intensity values within ROIs were run through the fitting algorithm, and a parametric map-based method in which individual signal intensities were run through the fitting algorithm pixel by pixel. Agreement between ROI- and map-based PDFF estimation was assessed by Bland-Altman and intraclass correlation (ICC) analysis.
RESULTS: Depending on the condition and method, PDFF ranged from -2.52% to 45.57%. Over all conditions, mean differences between ROI- and map-based PDFF estimates ranged from 0.04% to 0.24%, with all ICCs ≥0.999.
CONCLUSION: Agreement between ROI- and parametric map-based PDFF estimation is excellent over a wide range of imaging and analysis conditions.

Entities:  

Keywords:  Analysis methods; Fat quantification; Hepatic steatosis; MRI; PDFF; Proton density fat fraction; QIB; Quantitative imaging biomarker

Mesh:

Substances:

Year:  2017        PMID: 27688063      PMCID: PMC5357163          DOI: 10.1007/s00261-016-0925-2

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  19 in total

1.  Relaxation effects in the quantification of fat using gradient echo imaging.

Authors:  Mark Bydder; Takeshi Yokoo; Gavin Hamilton; Michael S Middleton; Alyssa D Chavez; Jeffrey B Schwimmer; Joel E Lavine; Claude B Sirlin
Journal:  Magn Reson Imaging       Date:  2008-02-21       Impact factor: 2.546

2.  Fat quantification with IDEAL gradient echo imaging: correction of bias from T(1) and noise.

Authors:  Chia-Ying Liu; Charles A McKenzie; Huanzhou Yu; Jean H Brittain; Scott B Reeder
Journal:  Magn Reson Med       Date:  2007-08       Impact factor: 4.668

3.  Reproducibility of MR-based liver fat quantification across field strength: Same-day comparison between 1.5T and 3T in obese subjects.

Authors:  Nathan S Artz; William M Haufe; Catherine A Hooker; Gavin Hamilton; Tanya Wolfson; Guilherme M Campos; Anthony C Gamst; Jeffrey B Schwimmer; Claude B Sirlin; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2015-01-23       Impact factor: 4.813

4.  Reproducibility of MRI-determined proton density fat fraction across two different MR scanner platforms.

Authors:  Geraldine H Kang; Irene Cruite; Masoud Shiehmorteza; Tanya Wolfson; Anthony C Gamst; Gavin Hamilton; Mark Bydder; Michael S Middleton; Claude B Sirlin
Journal:  J Magn Reson Imaging       Date:  2011-07-18       Impact factor: 4.813

5.  Measurement of signal intensities in the presence of noise in MR images.

Authors:  R M Henkelman
Journal:  Med Phys       Date:  1985 Mar-Apr       Impact factor: 4.071

6.  Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis.

Authors:  An Tang; Justin Tan; Mark Sun; Gavin Hamilton; Mark Bydder; Tanya Wolfson; Anthony C Gamst; Michael Middleton; Elizabeth M Brunt; Rohit Loomba; Joel E Lavine; Jeffrey B Schwimmer; Claude B Sirlin
Journal:  Radiology       Date:  2013-02-04       Impact factor: 11.105

7.  Effects of intravenous gadolinium administration and flip angle on the assessment of liver fat signal fraction with opposed-phase and in-phase imaging.

Authors:  Takeshi Yokoo; Julie M Collins; Robert F Hanna; Mark Bydder; Michael S Middleton; Claude B Sirlin
Journal:  J Magn Reson Imaging       Date:  2008-07       Impact factor: 4.813

8.  Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T.

Authors:  Takeshi Yokoo; Mark Bydder; Gavin Hamilton; Michael S Middleton; Anthony C Gamst; Tanya Wolfson; Tarek Hassanein; Heather M Patton; Joel E Lavine; Jeffrey B Schwimmer; Claude B Sirlin
Journal:  Radiology       Date:  2009-02-12       Impact factor: 11.105

9.  Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease.

Authors:  An Tang; Ajinkya Desai; Gavin Hamilton; Tanya Wolfson; Anthony Gamst; Jessica Lam; Lisa Clark; Jonathan Hooker; Tanya Chavez; Brandon D Ang; Michael S Middleton; Michael Peterson; Rohit Loomba; Claude B Sirlin
Journal:  Radiology       Date:  2014-09-22       Impact factor: 11.105

10.  Effect of echo-sampling strategy on the accuracy of out-of-phase and in-phase multiecho gradient-echo MRI hepatic fat fraction estimation.

Authors:  Yakir S Levin; Takeshi Yokoo; Tanya Wolfson; Anthony C Gamst; Julie Collins; Emil A Achmad; Gavin Hamilton; Michael S Middleton; Rohit Loomba; Claude B Sirlin
Journal:  J Magn Reson Imaging       Date:  2013-05-29       Impact factor: 4.813

View more
  4 in total

1.  Accuracy of PDFF estimation by magnitude-based and complex-based MRI in children with MR spectroscopy as a reference.

Authors:  William M Haufe; Tanya Wolfson; Catherine A Hooker; Jonathan C Hooker; Yesenia Covarrubias; Alex N Schlein; Gavin Hamilton; Michael S Middleton; Jorge E Angeles; Diego Hernando; Scott B Reeder; Jeffrey B Schwimmer; Claude B Sirlin
Journal:  J Magn Reson Imaging       Date:  2017-03-21       Impact factor: 4.813

2.  Inter-reader agreement of magnetic resonance imaging proton density fat fraction and its longitudinal change in a clinical trial of adults with nonalcoholic steatohepatitis.

Authors:  Jonathan C Hooker; Gavin Hamilton; Charlie C Park; Steven Liao; Tanya Wolfson; Soudabeh Fazeli Dehkordy; Cheng William Hong; Adrija Mamidipalli; Anthony Gamst; Rohit Loomba; Claude B Sirlin
Journal:  Abdom Radiol (NY)       Date:  2019-02

3.  Diagnostic accuracy of magnetic resonance imaging hepatic proton density fat fraction in pediatric nonalcoholic fatty liver disease.

Authors:  Michael S Middleton; Mark L Van Natta; Elhamy R Heba; Adina Alazraki; Andrew T Trout; Prakash Masand; Elizabeth M Brunt; David E Kleiner; Edward Doo; James Tonascia; Joel E Lavine; Wei Shen; Gavin Hamilton; Jeffrey B Schwimmer; Claude B Sirlin
Journal:  Hepatology       Date:  2018-01-26       Impact factor: 17.425

4.  Estimating of hepatic fat amount using MRI proton density fat fraction in a real practice setting.

Authors:  Hyeyoung Lee; Dae Won Jun; Bo-Kyeong Kang; Eunwoo Nam; Misoo Chang; Mimi Kim; Soonyoung Song; Byung Chul Yoon; Hang Lak Lee; Oh Young Lee; Ho Soon Choi; Kang Nyeong Lee
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.